Drug company Actavis recently made a bid for Allergan, but the Botox maker rejected the proposal and is closing in on its own takeover for Salix Pharmaceuticals.
via WSJ.com: US Business http://ift.tt/XYOjN3
via WSJ.com: US Business http://ift.tt/XYOjN3
Nessun commento:
Posta un commento